CADL 5.31 (-4.67%)
US1374041093BiotechnologyBiotechnology

Candel Therapeutics (CADL) Stock Highlights

5.31 | -4.67%
2025-04-03 06:31:07
Candel Therapeutics Inc is a late clinical stage biopharmaceutical company. It is focused on helping patients fight cancer with oncolytic viral immunotherapies.

Statistics

Range Today
5.12 5.68
Volume Today 1.4M
Range 1 Year
1.56 14.6
Volume 1 Year 679.74M
Range 3 Year
0.66 14.6
Volume 3 Year 731.61M
Range 10 Year
0.66 14.78
Volume 10 Year 746.11M

Highlights

Market Capitalization 280.82M (small)
Floating Shares 35.93M
Current Price 5.31
Price To Earnings -4.01
Price To Book 4.2
Earnings Per Share -1.74
Payout Ratio 0%

Performance

Latest -4.67%
1 Month -41%
3 Months -37.97%
6 Months -23.71%
1 Year +200%
3 Years +2.12%
5 Years -35.56%
10 Years -35.56%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.